Developer docs
API playgroundTry for free, no card

Search company profiles

Devicare

Full company profile

uuid0002wda

Namestring
Devicare
Legal namestring
DEVICARE, SL.
Websiteurl
devicare.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Devicare, S.L. is a privately held Spanish pharmaceutical company founded in 2011 and headquartered in Sant Cugat del Vallès, Barcelona. The company specializes in urinary health solutions, with its core portfolio centered on the Lit-Control® product line for kidney stone prevention and management. Its offering comprises patented and clinically proven dietary supplements (Lit-Control pH Balance for calcium oxalate stones at €39.99, pH Up for uric acid stones, and pH Down for infectious-origin stones), a Bluetooth-enabled Lit-Control pH Meter 2.0 (€199.99) for at-home urinary pH monitoring, calibration accessories (pH Buffer, pH Sensor), and the myLit-Control mobile application that syncs with the meter to track water intake, pH levels, and supplement consumption. Adjacent product lines address urinary infections (Metiofitina®, Citrafitina®, Utipro® Plus AF), intimate hygiene (Urogelus®, Nodorin®), urinary catheter care (Canoxidin®), and osteoporosis (Savebone®), with an additional offering of online consultations (nutritionist, stomatherapy, 24-hour urinalysis interpretation, and kidney stone analysis at €49.99-€199.99).

Devicare operates a direct-to-consumer e-commerce business model, selling through localized storefronts serving Spain, Italy, France, Turkey, and Hungary, with free shipping above €50 and subscription options offering 5% discounts. The go-to-market is augmented by a B2B2C layer through urologists, family doctors, nurses, and pharmacists who recommend Devicare products, supported by dedicated professional and distributor portals. The company holds Spanish pharmaceutical authorization (6646-PS) to sell non-prescription medical devices and operates in full GDPR compliance. In February 2026, Devicare completed its first international acquisition of U.S.-based IP6 International, Inc. (manufacturer of the IP6 Gold® nutritional brand), financed by a €1.2 million loan from COFIDES through the FONPYME fund, marking entry into the U.S. pharmaceutical and nutraceutical market. Cumulative equity funding of approximately $13 million has been raised across rounds from 2016-2021, with investors including EMESA Corporación Empresarial, Ship2B, Avançsa, Boyser, ELADIET, Ona Capital, Peroxfarma, and ICF Capital. The company has 11-50 employees and no disclosed revenue figure.

Short descriptiontext

Devicare is a Spanish pharmaceutical company that sells patented dietary supplements, Bluetooth pH meters, and a companion mobile app (myLit-Control) for kidney stone prevention and broader urinary health, distributed via D2C e-commerce across Europe and the U.S.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSant Cugat Del Vallès, Spain
HQ citystring
Sant Cugat Del Vallès
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
urinary health products, kidney stone supplements, urology medical devices, dietary supplements, telemedicine consultations
Industry4 codes
PRIMARYHLAIAAAM
Nephrology & Urology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAGAE
Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity)
SECONDARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHSABAKAH
Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies)
Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services
NAICS code1 code
  • Food (Health) Supplement Retailers456191
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Medicinal Chemicals & Botanical Products2833
Product category
Urology pharmaceuticals and urinary health products
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Nutritional Supplement Sales
TypeOne Time License
Description

Sale of patented and clinically proven dietary supplements (Lit-Control pH Balance, pH Up, pH Down, Theobromine, Metiofitina, Citrafitina, Utipro Plus AF, Savebone) for urinary health, kidney stones, osteoporosis, and urinary infections. Products are sold directly to consumers through the e-commerce website with prices ranging from €9.99 to €54.99.

devicare.com
2Medical Device Sales
TypeOne Time License
Description

Sale of medical devices including the Lit-Control pH Meter 2.0 (€199.99), Lit-Control pH Sensor (€99.99), Canoxidin for urinary catheters (€54.99), and pH Buffer solution (€9.99). These are non-prescription medical devices sold directly to consumers.

devicare.com
3Online Consultation Services
TypeProfessional Services
Description

Professional consultation services including nutritionist consultation (€49.99), stomatherapy consultation, 24-hour urinalysis interpretation consultation, and kidney stone analysis. These services involve collaboration with healthcare professionals and clinical analysis laboratories.

devicare.com
4Intimate Hygiene Products
TypeOne Time License
Description

Sale of intimate hygiene products including Urogelus (€18.99) and Nodorin for managing odors due to unintentional leakages.

devicare.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Personnel, Technology or R&D, Operations
Pricing details4 tiers
1Dietary Supplements (Lit-Control pH Balance/Up/Down)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

€39.99 per unit. Gluten-free, dairy-free, vegan, sugar-free options available. Subscribe and save 5% with free periodic shipping and no permanence commitment.

devicare.com
2Medical Devices (pH Meter)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Lit-Control pH Meter 2.0: €199.99. Bluetooth-enabled device with app synchronization.

devicare.com
3Consultation Services
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Nutritionist consultation: €49.99. Additional consultations available (stomatherapy, urinalysis interpretation, kidney stone analysis).

devicare.com
4Intimate Hygiene & Infection Products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Urogelus: €18.99. Utipro Plus AF: €29.99. Metiofitina: €19.99. Canoxidin: €54.99. Various promotional offers available (e.g., 30% off Urogelus).

devicare.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1Lit-Control®
Description

Product line for kidney stone management including pH Balance, pH Up, pH Down, pH Meter 2.0, pH Buffer, and pH Sensor

devicare.com
+8 more records
Core offering1 text field

Devicare develops, brands and sells patented dietary supplements, medical devices and a companion mobile application focused on urinary health, primarily for the prevention, treatment and monitoring of kidney stones, urinary infections, intimate hygiene, urinary catheter care and osteoporosis. Its products are sold direct-to-consumer through its own multi-country e-commerce website with subscription options, paid online clinical consultations, and a dedicated portal for healthcare professional recommendations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Patient testimonials report no renal colic episodes for 5+ years with regular Lit-Control use
+2 more records
Product overview1 text field

Devicare is a Spanish pharmaceutical company offering a comprehensive portfolio of products and services focused on urinary health. The core offering centers on the Lit-Control® product line, which includes pH measurement devices (Lit-Control® pH Meter 2.0 with Bluetooth-enabled app sync), calibration accessories (pH Buffer, pH Sensor), and three clinically-proven dietary supplements (pH Balance for calcium oxalate stones, pH Up for uric acid stones, and pH Down for infectious stones). Supporting the device ecosystem is the myLit-control® App, which enables patients to monitor water intake, urinary pH, and supplement consumption with smart notifications. Beyond kidney stones, Devicare addresses adjacent conditions through intimate hygiene products (Urogelus®, Nodorin®), urinary infection treatments (Metiofitina®, Citrafitina®, Utipro® Plus AF), catheter care (Canoxidin®), and osteoporosis management (Savebone®). The portfolio also includes pure ingredient supplements (Theobromine) and online consultation services (nutritionist, stomatherapy, 24h urinalysis interpretation, kidney stone analysis). Recent international expansion through acquisition of U.S.-based IP6 International brings the IP6 Gold® brand into the portfolio.

Product and service20 records
1Lit-Control pH Balance
CategoryDietary supplement (kidney stones)
Description

Patented and clinically proven dietary supplement priced at €39.99 designed to reduce formation of calcium oxalate kidney stones and facilitate expulsion of residual fragments post-surgery; gluten-free, dairy-free, vegan, sugar-free and low-salt formulation for adult stone formers.

2Lit-Control pH Up
CategoryDietary supplement (kidney stones)
Description

Patented and clinically proven food supplement priced at €39.99 indicated for patients with uric acid kidney stones, supporting urinary alkalinization.

3Lit-Control pH Down
CategoryDietary supplement (kidney stones)
Description

Patented and clinically proven food supplement priced at €39.99 indicated for patients with kidney stones of infectious origin, supporting urinary acidification.

4Lit-Control pH Meter 2.0
CategoryMedical device (urinary pH monitoring)
Description

Bluetooth-enabled urinary pH measurement device priced at €199.99 designed for kidney stone patients to monitor and track urinary pH levels for stone prevention, with synchronization to the myLit-control mobile app.

5Lit-Control pH Buffer
CategoryMedical device accessory
Description

Buffer solution priced at €9.99 used to calibrate and maintain the accuracy of the Lit-Control pH Meter 2.0 device.

6Lit-Control pH Sensor
CategoryMedical device accessory
Description

Replacement urinary pH sensor priced at €99.99 for use with the Lit-Control pH Meter device.

7myLit-control App
CategoryMobile software application
Description

Mobile application for kidney stone patients that monitors daily water intake, urinary pH and dietary supplement intake, provides educational content and smart notifications, and synchronizes via Bluetooth with the Lit-Control pH Meter 2.0; available on Google Play and Apple App Store.

8Urogelus
CategoryIntimate hygiene product
Description

Intimate hygiene product priced at €18.99 designed to avoid unpleasant odors from unintentional leakages and to eliminate infections and dermatitis.

9Nodorin
CategoryIntimate hygiene product
Description

Intimate hygiene product priced at €18.99 for managing odors from unintentional leakages.

10Metiofitina
CategoryUrinary infection product
Description

Product priced at €19.99 for the treatment of urinary infections.

11Citrafitina
CategoryUrinary infection product
Description

Product priced at €19.99 for the treatment of urinary infections.

12Utipro Plus AF
CategoryUrinary infection product
Description

Product priced at €29.99 for the treatment of urinary infections.

13Canoxidin
CategoryUrinary catheter care product
Description

Product priced at €54.99 for the care and management of urinary catheters.

14Savebone
CategoryOsteoporosis / bone health product
Description

Product priced at €24.99 for osteoporosis treatment and bone health management.

15Theobromine
CategoryPure ingredient supplement
Description

Pure theobromine food supplement priced at €24.99, low in sugar, designed for patients who want to prevent or dissolve uric acid kidney stones.

16Nutritionist consultation
CategoryOnline clinical consultation
Description

Online consultation service priced at €49.99 with a clinical nutrition specialist for personalized dietary guidance related to urinary health.

17Stomatherapy consultation
CategoryOnline clinical consultation
Description

Online consultation priced at €49.99 with a stomatherapy nurse for specialized care guidance.

1824h urinalysis interpretation consultation
CategoryOnline clinical consultation
Description

Online interpretation service priced at €49.99 for 24-hour urinalysis results, with professional analysis and guidance.

1924h urinalysis interpretation consultation and report
CategoryOnline clinical consultation
Description

Comprehensive 24-hour urinalysis interpretation service priced at €99.99, including a detailed written report.

20Kidney stone analysis
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Laboratory for Renal Lithiasis Research (LILR) - University of the Balearic Islands
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Devicare partners with the LILR of the University of the Balearic Islands for pathological anatomy services related to kidney stone analysis. Samples are sent to the laboratory for analysis, and the laboratory uses information both for sample analysis (under Devicare's responsibility) and for scientific research.

devicare.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

U.S.-based manufacturer of IP6 Gold nutritional products, acquired by Devicare in February 2026. This acquisition marks Devicare's first international expansion and entry into the U.S. market, combining IP6 International's brand and commercial platform with Devicare's scientific expertise in IP6.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based specialty pharmaceutical company with a dedicated urology portfolio including kidney-stone management and urinary-health products. Closely comparable to Devicare in therapeutic focus and physician-recommended D2C/promotional model.

TypeDirect peer
Description

Manufacturer of effervescent and specialty dietary supplements, including urinary-health and pH-balancing products. Comparable to Devicare in the specialty-condition supplement manufacturing and brand-build model.

TypeDirect peer
Description

Premium DTC dietary-supplement brand with practitioner-channel and consumer e-commerce distribution. Comparable in DTC supplement positioning, scientific credibility emphasis and subscription model.

TypeDirect peer
Description

Practitioner-grade supplement brand sold via healthcare professionals and direct channels. Comparable in clinically oriented, condition-targeted supplement positioning serving urinary and metabolic health segments.

TypeBroad incumbent
Description

Global leader in ostomy, continence and wound-care products, including catheter care. Comparable to Devicare's Canoxidin® catheter-care line, though operating at vastly larger scale across multiple geographies.

TypeBroad incumbent
Description

Global medical-products company with an ostomy and continence-care franchise. Comparable in catheter and continence product categories addressed by Devicare's catheter-care line.

TypeBroad incumbent
Description

Large-cap medical-device company with a significant urology and pelvic-health franchise. Comparable as a urology-focused device-and-therapy operator, though addressing surgical/procedural rather than home-monitoring use cases.

TypeEmerging player
Description

Specialty manufacturer of shock-wave and urology devices including lithotripsy systems for kidney stones. Comparable in the kidney-stone treatment space, with overlap on hardware used in stone management.

TypeEmerging player
Description

Specialty medtech focused on preventing acute kidney injury and contrast-induced nephropathy. Adjacent but comparable as a kidney-focused specialty medical company targeting nephrology/urology patients.

TypeEmerging player
Description

Long-standing DTC dietary-supplement brand with condition-targeted formulations and a strong e-commerce subscription model. Comparable in DTC supplement distribution and clinical-positioning strategy.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Devicare

Urology pharmaceuticals and urinary health productsdevicare.com

Devicare is a Spanish pharmaceutical company that sells patented dietary supplements, Bluetooth pH meters, and a companion mobile app (myLit-Control) for kidney stone prevention and broader urinary health, distributed via D2C e-commerce across Europe and the U.S.

What Devicare does

Devicare, S.L. is a privately held Spanish pharmaceutical company founded in 2011 and headquartered in Sant Cugat del Vallès, Barcelona. The company specializes in urinary health solutions, with its core portfolio centered on the Lit-Control® product line for kidney stone prevention and management. Its offering comprises patented and clinically proven dietary supplements (Lit-Control pH Balance for calcium oxalate stones at €39.99, pH Up for uric acid stones, and pH Down for infectious-origin stones), a Bluetooth-enabled Lit-Control pH Meter 2.0 (€199.99) for at-home urinary pH monitoring, calibration accessories (pH Buffer, pH Sensor), and the myLit-Control mobile application that syncs with the meter to track water intake, pH levels, and supplement consumption. Adjacent product lines address urinary infections (Metiofitina®, Citrafitina®, Utipro® Plus AF), intimate hygiene (Urogelus®, Nodorin®), urinary catheter care (Canoxidin®), and osteoporosis (Savebone®), with an additional offering of online consultations (nutritionist, stomatherapy, 24-hour urinalysis interpretation, and kidney stone analysis at €49.99-€199.99).

Devicare operates a direct-to-consumer e-commerce business model, selling through localized storefronts serving Spain, Italy, France, Turkey, and Hungary, with free shipping above €50 and subscription options offering 5% discounts. The go-to-market is augmented by a B2B2C layer through urologists, family doctors, nurses, and pharmacists who recommend Devicare products, supported by dedicated professional and distributor portals. The company holds Spanish pharmaceutical authorization (6646-PS) to sell non-prescription medical devices and operates in full GDPR compliance. In February 2026, Devicare completed its first international acquisition of U.S.-based IP6 International, Inc. (manufacturer of the IP6 Gold® nutritional brand), financed by a €1.2 million loan from COFIDES through the FONPYME fund, marking entry into the U.S. pharmaceutical and nutraceutical market. Cumulative equity funding of approximately $13 million has been raised across rounds from 2016-2021, with investors including EMESA Corporación Empresarial, Ship2B, Avançsa, Boyser, ELADIET, Ona Capital, Peroxfarma, and ICF Capital. The company has 11-50 employees and no disclosed revenue figure.

Devicare firmographics

Firmographics
Name
Devicare
Legal name
DEVICARE, SL.
Website
https://devicare.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
11–50 employees
Short description
Devicare is a Spanish pharmaceutical company that sells patented dietary supplements, Bluetooth pH meters, and a companion mobile app (myLit-Control) for kidney stone prevention and broader urinary health, distributed via D2C e-commerce across Europe and the U.S.
Ownership category
akta.pro rank

Devicare industry classification

Industry
Product category
Urology pharmaceuticals and urinary health products
NAICS
Food (Health) Supplement Retailers (456191)
SIC
Surgical & Medical Instruments & Apparatus (3841), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAIAAAM
Nephrology & Urology Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAGAE
Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity)
SECONDARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHSABAKAH
Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies)
Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services

Keywords

  • Urinary health products
  • Kidney stone supplements
  • Urology medical devices
  • Dietary supplements
  • Telemedicine consultations

Where Devicare is headquartered

Location

Headquarters

HQ city
Sant Cugat Del Vallès
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Devicare business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Personnel, Technology or R&D, Operations

Revenue model

  1. Nutritional Supplement Sales: Sale of patented and clinically proven dietary supplements (Lit-Control pH Balance, pH Up, pH Down, Theobromine, Metiofitina, Citrafitina, Utipro Plus AF, Savebone) for urinary health, kidney stones, osteoporosis, and urinary infections. Products are sold directly to consumers through the e-commerce website with prices ranging from €9.99 to €54.99.
  2. Medical Device Sales: Sale of medical devices including the Lit-Control pH Meter 2.0 (€199.99), Lit-Control pH Sensor (€99.99), Canoxidin for urinary catheters (€54.99), and pH Buffer solution (€9.99). These are non-prescription medical devices sold directly to consumers.
  3. Online Consultation Services: Professional consultation services including nutritionist consultation (€49.99), stomatherapy consultation, 24-hour urinalysis interpretation consultation, and kidney stone analysis. These services involve collaboration with healthcare professionals and clinical analysis laboratories.
  4. Intimate Hygiene Products: Sale of intimate hygiene products including Urogelus (€18.99) and Nodorin for managing odors due to unintentional leakages.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goDietary Supplements (Lit-Control pH Balance/Up/Down)
Unit PricingPay-as-you-goMedical Devices (pH Meter)
Unit PricingPay-as-you-goConsultation Services
Unit PricingPay-as-you-goIntimate Hygiene & Infection Products

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Devicare product offering

Product offering

Core offering

Devicare develops, brands and sells patented dietary supplements, medical devices and a companion mobile application focused on urinary health, primarily for the prevention, treatment and monitoring of kidney stones, urinary infections, intimate hygiene, urinary catheter care and osteoporosis. Its products are sold direct-to-consumer through its own multi-country e-commerce website with subscription options, paid online clinical consultations, and a dedicated portal for healthcare professional recommendations.

Product overview

Devicare is a Spanish pharmaceutical company offering a comprehensive portfolio of products and services focused on urinary health. The core offering centers on the Lit-Control® product line, which includes pH measurement devices (Lit-Control® pH Meter 2.0 with Bluetooth-enabled app sync), calibration accessories (pH Buffer, pH Sensor), and three clinically-proven dietary supplements (pH Balance for calcium oxalate stones, pH Up for uric acid stones, and pH Down for infectious stones). Supporting the device ecosystem is the myLit-control® App, which enables patients to monitor water intake, urinary pH, and supplement consumption with smart notifications. Beyond kidney stones, Devicare addresses adjacent conditions through intimate hygiene products (Urogelus®, Nodorin®), urinary infection treatments (Metiofitina®, Citrafitina®, Utipro® Plus AF), catheter care (Canoxidin®), and osteoporosis management (Savebone®). The portfolio also includes pure ingredient supplements (Theobromine) and online consultation services (nutritionist, stomatherapy, 24h urinalysis interpretation, kidney stone analysis). Recent international expansion through acquisition of U.S.-based IP6 International brings the IP6 Gold® brand into the portfolio.

Differentiator

Problem solved

Functional benefit

Brands

  • Lit-Control®: Product line for kidney stone management including pH Balance, pH Up, pH Down, pH Meter 2.0, pH Buffer, and pH Sensor
  • myLit-control® App
  • Urogelus®
  • Nodorin®
  • Metiofitina®
  • Citrafitina®
  • Utipro® Plus AF
  • Canoxidin®
  • Savebone®

Products and services

  • Lit-Control pH Balance Patented and clinically proven dietary supplement priced at €39.99 designed to reduce formation of calcium oxalate kidney stones and facilitate expulsion of residual fragments post-surgery; gluten-free, dairy-free, vegan, sugar-free and low-salt formulation for adult stone formers.
  • Lit-Control pH Up Patented and clinically proven food supplement priced at €39.99 indicated for patients with uric acid kidney stones, supporting urinary alkalinization.
  • Lit-Control pH Down Patented and clinically proven food supplement priced at €39.99 indicated for patients with kidney stones of infectious origin, supporting urinary acidification.
  • Lit-Control pH Meter 2.0 Bluetooth-enabled urinary pH measurement device priced at €199.99 designed for kidney stone patients to monitor and track urinary pH levels for stone prevention, with synchronization to the myLit-control mobile app.
  • Lit-Control pH Buffer Buffer solution priced at €9.99 used to calibrate and maintain the accuracy of the Lit-Control pH Meter 2.0 device.
  • Lit-Control pH Sensor Replacement urinary pH sensor priced at €99.99 for use with the Lit-Control pH Meter device.
  • myLit-control App Mobile application for kidney stone patients that monitors daily water intake, urinary pH and dietary supplement intake, provides educational content and smart notifications, and synchronizes via Bluetooth with the Lit-Control pH Meter 2.0; available on Google Play and Apple App Store.
  • Urogelus Intimate hygiene product priced at €18.99 designed to avoid unpleasant odors from unintentional leakages and to eliminate infections and dermatitis.
  • Nodorin Intimate hygiene product priced at €18.99 for managing odors from unintentional leakages.
  • Metiofitina Product priced at €19.99 for the treatment of urinary infections.
  • Citrafitina Product priced at €19.99 for the treatment of urinary infections.
  • Utipro Plus AF Product priced at €29.99 for the treatment of urinary infections.
  • Canoxidin Product priced at €54.99 for the care and management of urinary catheters.
  • Savebone Product priced at €24.99 for osteoporosis treatment and bone health management.
  • Theobromine Pure theobromine food supplement priced at €24.99, low in sugar, designed for patients who want to prevent or dissolve uric acid kidney stones.
  • Nutritionist consultation Online consultation service priced at €49.99 with a clinical nutrition specialist for personalized dietary guidance related to urinary health.
  • Stomatherapy consultation Online consultation priced at €49.99 with a stomatherapy nurse for specialized care guidance.
  • 24h urinalysis interpretation consultation Online interpretation service priced at €49.99 for 24-hour urinalysis results, with professional analysis and guidance.
  • 24h urinalysis interpretation consultation and report Comprehensive 24-hour urinalysis interpretation service priced at €99.99, including a detailed written report.
  • Kidney stone analysis

Quantifiable outcome

  • Patient testimonials report no renal colic episodes for 5+ years with regular Lit-Control use
  • +2 more outcomes

Companies that use Devicare

Customer profile

Segments5 records

Ideal customer profiles3 records

Devicare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

Feature4 records

Devicare partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Laboratory for Renal Lithiasis Research (LILR) - University of the Balearic IslandscoreStrategic or Co-development PartnerDevicare partners with the LILR of the University of the Balearic Islands for pathological anatomy services related to kidney stone analysis. Samples are sent to the laboratory for analysis, and the laboratory uses information both for sample analysis (under Devicare's responsibility) and for scientific research.
  • IP6 International, Inc.coreStrategic or Co-development PartnerU.S.-based manufacturer of IP6 Gold nutritional products, acquired by Devicare in February 2026. This acquisition marks Devicare's first international expansion and entry into the U.S. market, combining IP6 International's brand and commercial platform with Devicare's scientific expertise in IP6.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Devicare competitors and assessment

Company assessment

Direct peers

  • Mission Pharmacal: US-based specialty pharmaceutical company with a dedicated urology portfolio including kidney-stone management and urinary-health products. Closely comparable to Devicare in therapeutic focus and physician-recommended D2C/promotional model.
  • Amerilab Technologies: Manufacturer of effervescent and specialty dietary supplements, including urinary-health and pH-balancing products. Comparable to Devicare in the specialty-condition supplement manufacturing and brand-build model.
  • Thorne: Premium DTC dietary-supplement brand with practitioner-channel and consumer e-commerce distribution. Comparable in DTC supplement positioning, scientific credibility emphasis and subscription model.
  • Pure Encapsulations: Practitioner-grade supplement brand sold via healthcare professionals and direct channels. Comparable in clinically oriented, condition-targeted supplement positioning serving urinary and metabolic health segments.

Broad incumbents

  • Coloplast: Global leader in ostomy, continence and wound-care products, including catheter care. Comparable to Devicare's Canoxidin® catheter-care line, though operating at vastly larger scale across multiple geographies.
  • ConvaTec: Global medical-products company with an ostomy and continence-care franchise. Comparable in catheter and continence product categories addressed by Devicare's catheter-care line.
  • Boston Scientific: Large-cap medical-device company with a significant urology and pelvic-health franchise. Comparable as a urology-focused device-and-therapy operator, though addressing surgical/procedural rather than home-monitoring use cases.

Emerging players

  • STORZ Medical: Specialty manufacturer of shock-wave and urology devices including lithotripsy systems for kidney stones. Comparable in the kidney-stone treatment space, with overlap on hardware used in stone management.
  • RenalGuard Solutions: Specialty medtech focused on preventing acute kidney injury and contrast-induced nephropathy. Adjacent but comparable as a kidney-focused specialty medical company targeting nephrology/urology patients.
  • Life Extension: Long-standing DTC dietary-supplement brand with condition-targeted formulations and a strong e-commerce subscription model. Comparable in DTC supplement distribution and clinical-positioning strategy.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Devicare social profiles

Digital presence

Devicare compliance and trust

Trust signal

Compliance2 records

Devicare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Devicare leadership team

Management profile

Number of profiles

Profiles1 record

Devicare subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Devicare funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Devicare M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Devicare

What does Devicare do?

Devicare develops, brands and sells patented dietary supplements, medical devices and a companion mobile application focused on urinary health, primarily for the prevention, treatment and monitoring of kidney stones, urinary infections, intimate hygiene, urinary catheter care and osteoporosis. Its products are sold direct-to-consumer through its own multi-country e-commerce website with subscription options, paid online clinical consultations, and a dedicated portal for healthcare professional recommendations.

Is Devicare a public or private company?

Devicare is a private company. It is classified as venture growth investor backed and is currently operating.

When was Devicare founded?

Devicare was founded in 2011. It employs 11 to 50 people.

Where is Devicare based?

Devicare is headquartered in Sant Cugat Del Vallès, Spain, in the Europe region.

How does Devicare make money?

Four revenue lines are on record. Nutritional Supplement Sales are the primary driver. The others are medical Device Sales, online Consultation Services and intimate Hygiene Products.

Who are Devicare's main competitors?

Direct peers on record are Mission Pharmacal, Amerilab Technologies, Thorne and Pure Encapsulations. Broad incumbents are Coloplast, ConvaTec and Boston Scientific. Emerging players are STORZ Medical, RenalGuard Solutions and Life Extension.

Does Devicare have an API?

No public API is recorded for Devicare.

What industry is Devicare in?

Devicare's product category is Urology pharmaceuticals and urinary health products. Its primary akta.pro industry code is HLAIAAAM, Nephrology & Urology Pharmaceuticals, with a secondary code of CRADAGAE, Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity). Its NAICS code is 456191 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
DealertDevicare, S.L. acquires IP6 International, Inc.Spanish pharmaceutical company Devicare, S.L. has acquired U.S.-based nutritional products manufacturer IP6 International, Inc., marking Devicare's first international expansion into the United States. The acquisition was facilitated by a €1.2 million loan secured from COFIDES, Spain's development finance institution. IP6 International is recognized for its IP6 Gold® brand of nutritional products.LinkedIn#ip6 #devicare #cofides #growth #acquisition #usa #urologyDevicare has completed the acquisition of IP-6 International, Inc., a U.S.-based manufacturer of the IP6 Gold® brand, with co-financing support from COFIDES. This transaction represents Devicare's first international acquisition and marks its entry into the U.S. market, the world's largest pharmaceutical and nutraceutical market. The acquisition is positioned as a key step in Devicare's global growth strategy, combining IP-6 International's brand and commercial platform with Devicare's scientific expertise in IP6.Empresas de Capital Riesgo en EspaCOFIDES supports Devicare’s Expansion in the United States with a €1.2 million loanCOFIDES, a Spanish state-owned development finance institution, has granted a €1.2 million loan to Devicare, S.L. through the FONPYME fund to support its acquisition of IP6 International, Inc., a U.S.-based manufacturer of nutritional products including IP6 Gold\u00ae. This transaction marks Devicare\u2019s first international acquisition and entry into the United States, which is described as the world\u2019s largest pharmaceutical and nutraceutical market. The financing will enable Devicare to complete the acquisition and establish a presence in the U.S. market as part of broader North American expansion plans.Ship2B FoundationShip2B invierte en Devicare a través de Equity4GoodShip2B invested $3 million in Devicare through its Equity4Good vehicle, co-financed by the European Investment Fund. The funds will develop the second-generation Lit-Control pH meter for kidney stone treatment, led by Advanced MedTech Holdings. The device aims to personalize therapy via urinary pH monitoring and remote management.GlobeNewswireGLOBAL UROLOGY LEADER ADVANCED MEDTECH LEADS DEVICARE’S USD$3 MILLION SERIES A FUNDRAISING TO BRING UROLOGICAL MEDICAL FOODS AND DIGITALIZED MANAGEMENT MEDICAL DEVICES TO MARKETAdvanced MedTech led a $3 million Series A funding round in Devicare, a Barcelona-based startup, to develop urological treatments combining nutritional therapy with digital monitoring. The funds will support a digital pH meter and app for kidney stone patients, and existing investors participated. The partnership aims to expand Devicare's offerings globally.Nordic 9Devicare to raise $3 million from Advanced MedTechDevicare, a Barcelona-based digital therapeutic company, closed a $3 million Series A led by Advanced MedTech. The funds will develop its Lit-Control device for kidney stone patients, a pH meter connected to a mobile app. The company previously raised EUR 3 million in 2019.BarcinnoThe 15 Most Disruptive Barcelona Healthtech StartupsBarcelona's healthtech ecosystem includes about 200 startups, with 19% at advanced funding stages. The article profiles 15 companies, including Psious, Devicare, and Top Doctors, detailing their products, funding rounds, and growth plans.PlantaDoceDevicare aterriza en Estados Unidos: firma una alianza con Diem LabsDevicare, a Spanish medical company, has partnered with Diem Labs to enter the US market, presenting its kidney stone treatment device Lit-Control at the American Urological Association congress in Chicago on May 3. The device is still undergoing FDA validation, and Devicare plans a 1.5 million euro funding round via Capital Cell.FinSMEsDevicare Signs €2M Participative LoanDevicare, a Barcelona-based medical device company, signed a €2M participative loan from Avançsa's Innova Global line. The loan includes an option to convert into Series A stock and will fund R&D and clinical trials for remote patient monitoring devices. The company currently offers urinary disease and anticoagulant self-management products.FinSMEsDevicare Receives €133K Participation Loan from the Catalan Finance InstituteDevicare, a Barcelona-based medical device company, received a €133K participation loan from the Catalan Finance Institute and ACCIÓ. The funds will support sales of its remote patient monitoring products, Lit-Control and Tao-Control, for chronic home care.